Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma

Cancer

Volumn 80, Issue 5, 1997, Pages 865-872

  Piao, Zhe ^a   Kim, Hoguen ^a   Jeon, Bong Kyun ^a   Lee, Woo Jung ^a   Park, Chanil ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Differentiation; Hepatocellular carci noma; Loss of heterozygosity; Tumor suppressor genes

Indexed keywords

PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; FEMALE; GENE TARGETING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; LIVER NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 0030876720     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970901)80:5<865::AID-CNCR6>3.0.CO;2-K     Document Type: Article

References (50)

1. Simonetti RG, Camma C, Fiorello F, Politti F, D'amico G, Pagliaro L. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci 1991;36:962-72.
2. Harris CC. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells 1990;2:146-8.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
4. Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, et al. Mutation of the p53 gene in human soft tissue sarcoma: association with abnormalities of the Rb1 gene. Oncogene 1990;5:1297-301.
5. Scheffner M, Munger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991;88:5523-7.
6. Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weishselbaum RR. P53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Res 1991;51:6393-6.
7. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991; 51:5520-5.
8. Brewster SF, Browne S, Brown KW. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 1994;151:1073-7.
9. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci USA 1993;90:10914-21.
10. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS. Alterations of tumor suppressor gene and allelic losses in human hepatocellular carcinomas in China. Cancer Res 1994;54:281-5.
11. Zhang X, Xu HJ, Murakami Y, Sachse R, Yashima K, Hirohashi S, et al. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994;54:4177-82.
12. Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N, et al. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol 1995;10:179-85.
13. Goelz SE, Hamiton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-26.
14. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
15. Jones MH, Yamakawa K, Nakamura Y. Isolation and characterisation of 19 dinucleotide repeat polymorphisms on chromosome 3p. Hum Mol Genet 1992;1:131-3.
16. van Leeuwen C, Tops C, Breukel C, van der Klift H, Deaven L, Fodde R, et al. CA repeat polymporphism at the D5S299 locus linked to adenomatous polyposis coli (APC). Nucleic Acids Res 1991;19:5805.
17. Breukel C, Tops C, van Leeuwen C, van der Klift H, Nakamura Y, Fodde R, et al. CA repeat polymporphism at the D5S82 locus, proximal to adenomatous adenomatous polyposis coli (APC). Nucleic Acids Res 1991;19:5804.
18. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome 11 and loss of heterozygosity for EXT-linked markers on chromosomes 11 and 8. Am J Hum Genet 1995;56:1125-31.
19. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilm's tumor. Cell 1990;61:1257-69.
20. Yandell DW, Dryja TP. Detection of DNA polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet 1989;45:547-55.
21. Jones M, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using dinucleotide repeat polymorphism. Genes Chromosom Cancer 1992;5:89-90.
22. Futreal PA, Barrett JC, Wiseman RW. An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res 1991;19:6977.
23. Cropp CS, Nevanlinna HA, Pyrhonen S, Stenman UH, Salmikangas P, Albertsen H, et al. Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res 1994; 54:2548-51.
24. Hall JM, Friedman L, Guenther C, Lee MK, Weber JL, Black DM, et al. Closing in on a breast cancer gene on chromsome 17q. Am J Hum Genet 1992;50:1235-42.
25. Risinger JI, Boyd J. Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21. Hum Mol Genet 1992;1:657.
26. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 1992;52:6525-30.
27. Gruis NA, Abeln ECA, Bardoel AFJ, Devilee P, Frants RR, Cornelisse CJ. PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. Br J Cancer 1993;68:308-13.
28. Cawkwell L, Lewis FA, Quirke P. Frequency of allele of DCC, p53, Rb1, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1994;70:813-8.
29. Peng HQ, Bailey D, Bronson D, Goss PE, Hogg D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 1995;55:2871-5.
30. Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y. Loss of heterozygosity at the p53, Rb, DCC and APC tumor suppressor gene loci in human bladder cancer. J Urol 1996;155: 1444-7.
31. Hsu HC, Peng SY, Lai PL, Sheu JC, Chen DS, Lin LI. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. Cancer 1994;73:42-7.
32. Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology 1995;22:1702-7.
33. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-31.
34. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Muatation hot spot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-8.
35. Soini Y, Chia SC, Bennett WP, Groopman JD, Wang JS, De-Benedetti VMG, et al. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis 1996;17:1007-12.
36. Kim JH, Park JB, Misudomi T, Choi JJ, Yoo NC, Choi JH, et al. p53 gene mutation in hepatocellular carcinoma from Korean patients and in established hepatocellular carcinoma cell lines. J Korean Cancer 1993;25:359-67.
37. Cook A, Raskind W, Blanton SH, Pauli RM, Gregg RG, Francomano CA, et al. Genetic heterogeneity in families with hereditary multiple exostoses. Am J Hum Genet 1993;53:71-9.
38. Ahn J, Ludecke HJ, Lindow S, Horton WA, Lee B, Wagner MJ, et al. Cloning of the putative tumour suppressor gene for heteditary multiple exostoses (EXT1). Nat Genet 1995; 11:137-43.
39. Mertens F, Rydholm A, Kreicbergs A, Willen H, Jonsson K, Heim S, et al. Loss of chromosome band 8q24 in sporadic osteocartilaginous exostoses. Genes Chromosom Cancer 1994;9:8-12.
40. Raskind WH, Conrad EU, Chansky H, Matsushita M. Loss of heterozygosity in chondrosarcomas for hereditary multiple exostoses-linked markers on chromosomes 8 and 11. Am J Hum Genet 1995;56:1132-9.
41. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, et al. Allelotype of colorectal carcinomas. Science 1989;244:207-11.
42. Fults D, Pedone CA, Thomas GA, White R. Allelotype of human malignant astrocytoma. Cancer Res 1990;50:5784-9.
43. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, et al. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 1995;72:1180-3.
44. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, et al. Allelotyping of ductal carcinoma in situ of the breast deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 1995;55:3399-405.
45. Takeuchi S, Bartram CR, Wada M, Reiter A, Hatta Y, Seriu T, et al. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995;55:5377-82.
46. Hahn SA, Seymour AB, Shamsul Hoque ATM, Schutte M, Cost LT, Redston MS, et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995;55: 4670-5.
47. Johns MM III, Westra WH, Califano JA, Eisele D, Koch WM, Sidransky D. Allelotype of salivary gland tumors. Cancer Res 1996;56:1151-4.
48. Kenmochi K, Sugihara S, Kojiro M. Relationship of histological grade of hepatocellular carcinoma (HCC) to tumor size and demonstration of tumor cells of multiple different grades in single small HCC. Liver 1987;7:18-26.
49. Rim KS, Sakamoto M, Watanabe H, Matsuno Y, Nakanishi Y, Mukai K, et al. Pathology and DNA cytophotometry of small hepatocellular carcinoma with a nodule-in-nodule appearance: evidence for stepwise progression of hepatocellular carcinoma. Jpn J Clin Oncol 1993;23:26-33.
50. Choi BI, Takayasu K, Han MC. Small hepatocellular carcinomas and associated nodular lesions of the liver : pathology, pathogenesis, and imaging findings. AJR Am J Roentgenol 1993;160:1177-87.